In our study, we observed elevated phosphorylation levels of AMPK and changes in the expression of its downstream molecules, including SREBP‐1c, PPARα, CPT‐1, and FAS, following HP treatment in HCD‐fed NAFLD rats. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.